US FDA India boss quits but collaborative focus appears intact
This article was originally published in SRA
Executive Summary
The unexpected exit of Altaf Ahmed Lal from his position as director of the US Food and Drug Administration's office in India has left many questions unanswered, though there is optimism in the pharma industry that the agency's recent efforts to improve US-India co-operation in the area of drugs quality would stay on course.